Alzheimer's disease AP peptide binding to cell membranes is correlated to membrane surface phosphatidylserine levels.

被引：0
|
作者：
Arispe, Nelson J. [1 ]
Simakova, Olga [1 ]
机构：
[1] Uniformed Serv Univ Hlth Sci, Bethesda, MD USA
来源：
BIOPHYSICAL JOURNAL | 2007年
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：612A / 612A
页数：1
相关论文
共 50 条
  • [21] Cerebrospinal fluid dehydroepiandrosterone levels are correlated with brain dehydroepiandrosterone levels, elevated in Alzheimer's disease, and related to neuropathological disease stage
    Naylor, Jennifer C.
    Hulette, Christine M.
    Steffens, David C.
    Shampine, Lawrence J.
    Ervin, John F.
    Payne, Victoria M.
    Massing, Mark W.
    Kilts, Jason D.
    Strauss, Jennifer L.
    Calhoun, Patrick S.
    Calnaido, Rohana P.
    Blazer, Daniel G.
    Lieberman, Jeffrey A.
    Madison, Roger D.
    Marx, Christine E.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (08): : 3173 - 3178
  • [22] Specific binding of Alzheimer amyloid peptides to the cell surface implicates the presence of a membrane receptor
    Bateman, D
    Gorman, PM
    Chakrabartty, A
    NEUROBIOLOGY OF AGING, 2004, 25 : S77 - S77
  • [23] Alterations of some membrane transport proteins in Alzheimer's disease:: role of amyloid β-peptide
    Sultana, Rukhsana
    Butterfield, D. Allan
    MOLECULAR BIOSYSTEMS, 2008, 4 (01) : 36 - 41
  • [24] Membrane Interactions of the Alzheimer's Disease Aβ42 Peptide and a Soluble Aβ42 Fusion Protein
    Weber, Daniel K.
    Sani, Marc-Antoine
    Separovic, Frances
    Gehman, John D.
    BIOPHYSICAL JOURNAL, 2013, 104 (02) : 238A - 238A
  • [25] NMR reveals anomalous copper(II) binding to the amyloid Aβ peptide of Alzheimer's disease
    Hou, Liming
    Zagorski, Michael G.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (29) : 9260 - 9261
  • [26] Characterization of Mn(II) ion binding to the amyloid-β peptide in Alzheimer's disease
    Wallin, Cecilia
    Kulkarni, Yashraj S.
    Abelein, Axel
    Jarvet, Juri
    Liao, Qinghua
    Strodel, Birgit
    Olsson, Lisa
    Luo, Jinghui
    Abrahams, Jan Pieter
    Sholts, Sabrina B.
    Roos, Per M.
    Kamerlin, Shina C. L.
    Graslund, Astrid
    Warmlander, Sebastian K. T. S.
    JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY, 2016, 38 : 183 - 193
  • [27] Model of Alzheimer's disease amyloid-β peptide based on a RNA binding protein
    Mathura, VS
    Paris, D
    Ait-Ghezala, G
    Quadros, A
    Patel, NS
    Kolippakkam, DN
    Volmar, CH
    Mullan, MJ
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 332 (02) : 585 - 592
  • [28] The experimental Alzheimer's disease drug posiphen [(+)-phenserine] lowers amyloid-β peptide levels in cell culture and mice
    Lahiri, Debomoy K.
    Chen, DeMao
    Maloney, Bryan
    Holloway, Harold W.
    Yu, Qian-sheng
    Utsuki, Tada
    Giordano, Tony
    Sambamurti, Kumar
    Greig, Nigel H.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 320 (01): : 386 - 396
  • [29] Cell Membrane Biomimetic Nanoparticles with Potential in Treatment of Alzheimer's Disease
    Zhong, Xinyu
    Na, Yue
    Yin, Shun
    Yan, Chang
    Gu, Jinlian
    Zhang, Ning
    Geng, Fang
    MOLECULES, 2023, 28 (05):
  • [30] Site-specific local environmental changes and membrane-peptide interactions of an Alzheimer's disease peptide
    Kent, Thomas
    Du, Deguo
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
12345